Clinical trials
Recruiting Phase 3 Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Novartis Pharmaceuticals | 2 |
| Alessandro Doria | 1 |
| Alnylam Pharmaceuticals | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Cantonal Hospital of St. Gallen | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 19 |
| Heart Failure | 4 |
| Aortic Valve Stenosis | 2 |
| Atherosclerosis | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyslipidemias | 2 |
| Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
| Hyperlipoproteinemia Type II | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.